Li Feng

Trials

Studies that name Li Feng as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:16 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06863831 · A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

  Cancer Institute and Hospital, Chinese Academy of Medical Sciences · enrolling by invitation · Esophageal Squamous Cell Carcinoma (ESCC) · study chair
• Ph3
  NCT06837597 · Jianzhong Qushi in Chronic RRI

  Cancer Institute and Hospital, Chinese Academy of Medical Sciences · not yet recruiting · Chronic Radiation Proctitis · study chair
• Ph2/Ph3
  NCT06324266 · Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

  Jinling Hospital, China · unknown · Newly Diagnosed Multiple Myeloma · principal investigator
• Ph3
  NCT05840341 · Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer

  Fudan University · completed · Pancreatic Neoplasms · study chair
• N/A
  NCT04840420 · An Effectiveness-implementation Hybrid Study of Social Prescribing in a Singapore Community Hospital Setting

  Bright Vision Hospital · unknown · Social Isolation · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 30 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.